Rakuten Medical, Inc., a global biotechnology company developing and commercializing Alluminox™ platform-based photoimmunotherapy, today announced that its third drug candidate, RM-0256, has been ...

Monoclonal antibodies against SARS-CoV-2 were considered a promising approach for the prevention and therapy of coronavirus ...

This country research report on Vietnam Cancer Monoclonal Antibody Market offers comprehensive insights into the market landscape, customer intelligence, and competitive strategies in the Vietnam ...

Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in ...

Merus N.V. (NASDAQ:MRUS), a clinical-stage oncology company with a market capitalization of $2.8 billion, has announced the publication detailing the mechanism of action for its investigational ...

Phanes Therapeutics begins patient dosing in clinical study of mavrostobart in combination with chemotherapy: San Diego Wednesday, May 28, 2025, 18:00 Hrs [IST] Phanes Therapeutic ...

Merus N.V. (NASDAQ:MRUS), a clinical-stage oncology company with a market capitalization of $2.8 billion, has announced the publication detailing the mechanism ... these antibodies share several ...

Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body's ...

Adding Blenrep to standard therapy prolonged progression-free survival in patients with relapsed or refractory multiple ...

DelveInsight's Chronic Kidney Disease pipeline report depicts a robust space with 75+ active players working to develop 80+ ...